These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


393 related items for PubMed ID: 17200145

  • 1. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M, Fellermann K, Fritz P, Wiedow O, Stange EF, Wehkamp J.
    J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
    [Abstract] [Full Text] [Related]

  • 2. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S, van der Linden AC, van Sterkenburg MA, Rabe KF, Schalkwijk J, Hiemstra PS.
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [Abstract] [Full Text] [Related]

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J.
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [Abstract] [Full Text] [Related]

  • 4. Adenoviral E1A suppresses secretory leukoprotease inhibitor and elafin secretion in human alveolar epithelial cells and bronchial epithelial cells.
    Higashimoto Y, Yamagata Y, Iwata T, Ishiguchi T, Okada M, Masuda M, Satoh H, Itoh H.
    Respiration; 2005 Dec; 72(6):629-35. PubMed ID: 16355004
    [Abstract] [Full Text] [Related]

  • 5. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
    Eriksson A, Jennische E, Flach CF, Jorge A, Lange S.
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
    [Abstract] [Full Text] [Related]

  • 6. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F, Giese T, Gassler N, Sido B, Heuschen G, Heuschen U, Zuna I, Schulz P, Weckauf H, Berger I, Otto HF, Meuer SC.
    Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
    [Abstract] [Full Text] [Related]

  • 7. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
    Moreau T, Baranger K, Dadé S, Dallet-Choisy S, Guyot N, Zani ML.
    Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
    [Abstract] [Full Text] [Related]

  • 8. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa.
    Wex T, Mönkemüller K, Kuester D, Weise S, Kropf S, Fry LC, Stahr A, Völkel S, Roessner A, Malfertheiner P.
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):150-8. PubMed ID: 19212204
    [Abstract] [Full Text] [Related]

  • 9. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
    Zani ML, Tanga A, Saidi A, Serrano H, Dallet-Choisy S, Baranger K, Moreau T.
    Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
    Nyström M, Westin UP, Linder C, Ohlsson K.
    Mediators Inflamm; 2001 Oct; 10(5):269-72. PubMed ID: 11759111
    [Abstract] [Full Text] [Related]

  • 13. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P, Kolios G, Drygiannakis I, Pyrovolaki K, Bourikas L, Papadaki HA, Kouroumalis E.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD, Kennedy JA, Zitnik RJ, Kashem MA.
    Biochem Biophys Res Commun; 1999 Jan 27; 254(3):614-7. PubMed ID: 9920787
    [Abstract] [Full Text] [Related]

  • 15. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Zhang W, Teng G, Wu T, Tian Y, Wang H.
    Inflamm Bowel Dis; 2017 Dec 27; 23(12):2134-2141. PubMed ID: 29084078
    [Abstract] [Full Text] [Related]

  • 16. SLPI and elafin: multifunctional antiproteases of the WFDC family.
    Scott A, Weldon S, Taggart CC.
    Biochem Soc Trans; 2011 Oct 27; 39(5):1437-40. PubMed ID: 21936829
    [Abstract] [Full Text] [Related]

  • 17. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R.
    J Pathol; 2008 Oct 27; 216(2):183-92. PubMed ID: 18729068
    [Abstract] [Full Text] [Related]

  • 18. Defensins and other antimicrobial peptides in inflammatory bowel disease.
    Wehkamp J, Schmid M, Stange EF.
    Curr Opin Gastroenterol; 2007 Jul 27; 23(4):370-8. PubMed ID: 17545771
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.